SIGA Technologies Inc (SIGA): מקדם מחיר להכנסות

SIGA Technologies, Inc. (SIGA) products in the commercial growth phase provide biodefense through multi-year government contracts. The company's P/S chart visualizes the asset's overheating, where the 3.70 mark indicates the market capitalization-to-revenue valuation level. The business relies on a supply monopoly of TPOXX for NATO and the US, generating revenue from procurement by various countries' ministries of health to build strategic stockpiles.

The P/S multiple determines the market value of one dollar of revenue, allowing an investor to assess the premium paid for the business's current sales volume. For SIGA Technologies, Inc. (SIGA), which is scaling deliveries to government stockpiles and expanding its drug portfolio, the company's average P/S reflects market expectations for future revenue diversification, helping to determine whether the capitalization is fair relative to operational successes.